FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2623762014> ?p ?o ?g. }

• W2623762014 endingPage "200" @default.
• W2623762014 startingPage "186" @default.
• W2623762014 abstract "Acrylamide (AA) exposure in 2-year cancer bioassays leads to thyroid, but not liver, adenomas and adenocarcinomas in rats. Hypothesized modes of action (MOAs) include genotoxicity/mutagenicity, or thyroid hormone dysregulation. To examine the plausibility of these two or any alternative MOAs, RNA-sequencing was performed on the thyroids and livers of AA-exposed rats, in parallel with measurement of genotoxicity (blood micronucleus and Pig-a mutant frequency) and serum thyroid hormone levels, following the exposure of male Fischer 344/DuCrl rats to 0.0, 0.5, 1.5, 3.0, 6.0, or 12.0 mg AA/kg bw-day in drinking water for 5, 15, or 31 days. Differentially expressed genes in both tissues provided marginal support for hormonal and genotoxic MOAs, which was consistent with negative/equivocal genotoxicity assay and marginal changes in thyroid hormone levels. Instead, there was a pronounced effect on calcium signaling/cytoskeletal genes in the thyroid. Benchmark dose modeling of RNA-sequencing data for the calcium signaling pathway suggests a point of departure (POD) of 0.68 mg/kg bw-day, which is consistent with a POD of 0.82 mg/kg bw-day derived from the thyroid 2-year cancer bioassay data. Overall, this study suggests a novel MOA for AA-induced thyroid carcinogenicity in male rats centered around perturbation of calcium signaling." @default.
• W2623762014 created "2017-06-15" @default.
• W2623762014 creator A5014534097 @default.
• W2623762014 creator A5036062143 @default.
• W2623762014 creator A5037354929 @default.
• W2623762014 creator A5068034103 @default.
• W2623762014 creator A5077375577 @default.
• W2623762014 creator A5078176247 @default.
• W2623762014 creator A5081189021 @default.
• W2623762014 date "2017-09-01" @default.
• W2623762014 modified "2023-10-18" @default.
• W2623762014 title "Transcriptional profiling of male F344 rats suggests the involvement of calcium signaling in the mode of action of acrylamide-induced thyroid cancer" @default.
• W2623762014 cites W1879098942 @default.
• W2623762014 cites W1887964547 @default.
• W2623762014 cites W1908738074 @default.
• W2623762014 cites W1924974311 @default.
• W2623762014 cites W1964188139 @default.
• W2623762014 cites W1964679905 @default.
• W2623762014 cites W1966890721 @default.
• W2623762014 cites W1979055768 @default.
• W2623762014 cites W1985961453 @default.
• W2623762014 cites W2002233209 @default.
• W2623762014 cites W2005482288 @default.
• W2623762014 cites W2017868878 @default.
• W2623762014 cites W2019201938 @default.
• W2623762014 cites W2021074697 @default.
• W2623762014 cites W2023685358 @default.
• W2623762014 cites W2024661178 @default.
• W2623762014 cites W2024805816 @default.
• W2623762014 cites W2024884089 @default.
• W2623762014 cites W2029214473 @default.
• W2623762014 cites W2034794220 @default.
• W2623762014 cites W2040607104 @default.
• W2623762014 cites W2057215289 @default.
• W2623762014 cites W2062366543 @default.
• W2623762014 cites W2065871079 @default.
• W2623762014 cites W2070703646 @default.
• W2623762014 cites W2074523155 @default.
• W2623762014 cites W2081921666 @default.
• W2623762014 cites W2082333679 @default.
• W2623762014 cites W2088331119 @default.
• W2623762014 cites W2101242849 @default.
• W2623762014 cites W2107018762 @default.
• W2623762014 cites W2111154757 @default.
• W2623762014 cites W2114104545 @default.
• W2623762014 cites W2116461220 @default.
• W2623762014 cites W2116934108 @default.
• W2623762014 cites W2121447924 @default.
• W2623762014 cites W2127076444 @default.
• W2623762014 cites W2131056742 @default.
• W2623762014 cites W2134453955 @default.
• W2623762014 cites W2136283706 @default.
• W2623762014 cites W2140307910 @default.
• W2623762014 cites W2145021394 @default.
• W2623762014 cites W2150220223 @default.
• W2623762014 cites W2150861334 @default.
• W2623762014 cites W2154976310 @default.
• W2623762014 cites W2155009153 @default.
• W2623762014 cites W2155491988 @default.
• W2623762014 cites W2161106528 @default.
• W2623762014 cites W2169456326 @default.
• W2623762014 cites W2170171012 @default.
• W2623762014 cites W2170551349 @default.
• W2623762014 cites W2174758411 @default.
• W2623762014 cites W2192432236 @default.
• W2623762014 cites W2206015331 @default.
• W2623762014 cites W2206373585 @default.
• W2623762014 cites W2253068585 @default.
• W2623762014 cites W2474944235 @default.
• W2623762014 cites W2596390648 @default.
• W2623762014 cites W2604154469 @default.
• W2623762014 cites W4251382791 @default.
• W2623762014 doi "https://doi.org/10.1016/j.fct.2017.06.019" @default.
• W2623762014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28606764" @default.
• W2623762014 hasPublicationYear "2017" @default.
• W2623762014 type Work @default.
• W2623762014 sameAs 2623762014 @default.
• W2623762014 citedByCount "16" @default.
• W2623762014 countsByYear W26237620142018 @default.
• W2623762014 countsByYear W26237620142020 @default.
• W2623762014 countsByYear W26237620142021 @default.
• W2623762014 countsByYear W26237620142022 @default.
• W2623762014 countsByYear W26237620142023 @default.
• W2623762014 crossrefType "journal-article" @default.
• W2623762014 hasAuthorship W2623762014A5014534097 @default.
• W2623762014 hasAuthorship W2623762014A5036062143 @default.
• W2623762014 hasAuthorship W2623762014A5037354929 @default.
• W2623762014 hasAuthorship W2623762014A5068034103 @default.
• W2623762014 hasAuthorship W2623762014A5077375577 @default.
• W2623762014 hasAuthorship W2623762014A5078176247 @default.
• W2623762014 hasAuthorship W2623762014A5081189021 @default.
• W2623762014 hasBestOaLocation W26237620141 @default.
• W2623762014 hasConcept C121587506 @default.
• W2623762014 hasConcept C126322002 @default.
• W2623762014 hasConcept C134018914 @default.
• W2623762014 hasConcept C2778959862 @default.
• W2623762014 hasConcept C29730261 @default.
• W2623762014 hasConcept C33070731 @default.

• next